Regenerative Medicine Market Analyzed Globally by Top Key Players, Trends, Share, Growth Rate and Forecast
The report “Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) — Forecast to 2021”
(firmenpresse) - report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Regenerative Medicine Market along with the estimates and forecasts of the revenue and market share analysis.
The Global Regenerative Medicine Market is expected to reach the US $38.70 Billion, at a CAGR of 23.6%.
The major factor driving the growth of this market, our government and private funding to support the development of regenerative medicine, the rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population.
Download PDF Brochure (Regenerative Medicines Market): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579
The report segments this market based on types, therapy, application, and regions.
Ethical concerns with the use of embryonic stem cell for R&D is a major factor restraining the growth of the market. Research in regenerative medicine necessitates the use of animals and humans in gene therapy studies that involve the recombination of genes and stem cell research therapies. These cells are also used for in vivo toxicity and pharmacokinetic testing of drugs that may harm animals and humans. In addition, stem cell research studies use human embryos for clinical applications that often lead to the destruction of the embryos.
Regenerative Medicine Market Dynamics:
Market Drivers:
Government & Private Funding to Support the Development of Regenerative Medicine
Rising Prevalence of Chronic Diseases and Genetic Disorders
Increase in Global Healthcare Expenditure
Rapid Growth in the Aging Population
Increase in Corporate Partnerships to Accelerate Development and Commercialization of Regenerative Medicine
Request Free Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579
Market Restraints:
Ethical Concerns with the Use of Embryonic Stem Cell for R&D
Lack of Clear Regulatory Guidelines
Market Opportunities:
Rising Demand for Organ Transplantation
Strong Product Pipeline
By application, orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is expected to account the fastest growing market owing to increasing prevalence of cancer globally and rich product pipeline and increasing demand for cancer treatments.
Speak To Our Subject Expert:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=65442579
Based on regions, the global Regenerative Medicine Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as technological advancement in the Regenerative medicine and rising incidences of chronic diseases and aging population.
Key players in the Regenerative Medicine Market include Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).
Themen in dieser Pressemitteilung:
regenerative-medicine
regenerative-medicine-market-key-players
regenerative-medicine-market-size
regenerative-medicine-industry
regenerative-medicine-market
regenerative-medicine-industry-analysis
regenerative-medicine-market-forecast
regenerative
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 13.03.2019 - 12:45 Uhr
Sprache: Deutsch
News-ID 589550
Anzahl Zeichen: 3857
contact information:
Contact person: shelly singh
Town:
northbrook
Phone: 18886006441
Kategorie:
Healthcare & Medical
Typ of Press Release: Financial
type of sending: send
Date of sending: 13.03.2019
Diese Pressemitteilung wurde bisher 107 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Regenerative Medicine Market Analyzed Globally by Top Key Players, Trends, Share, Growth Rate and Forecast"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
